Torner, L.; Toschi, N.; Pohlinger, A.; Landgraf, R.; Neumann, I. D.: Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling. Journal of Neuroscience 21, pp. 3207 - 3214 (2001)

Uhr, M.: Multiple Sklerose. Liquoranalyse in der MS-Diagnostik. Neurotransmitter 3, pp. 59 - 60 (2001)

Vetter, K.; Wurst, W.: Expression of a novel mouse gene ’mbFZb‘ in distinct regions of the developing nervous system and the adult brain. Mechanisms of Development 100, pp. 123 - 125 (2001)

Weber, F.: Multiple Sklerose. Experimentelle Therapien - Hoffnung für die Zukunft? Neurotransmitter 3, pp. 61 - 64 (2001)

Weber, F.; Neurath, H.; Desel, H.; Kitze, B.; Prange, H.: Rhabdomyolyse nach Einnahme von Venlafaxin (Trevilor®). Aktuelle Neurologie 28, pp. 132 - 134 (2001)

Wiedemann, K.; Jahn, H.; Yassouridis, A.; Kellner, M.: Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks. Archives of General Psychiatry 58, pp. 371 - 377 (2001)

Wiegers, G. J.; Stec, I. E. M.; Klinkert, W. E. F.; Linthorst, A. C. E.; Reul, J. M. H. M.: Bidirectional effects of corticosterone on splenic T-cell activation: Critical role of cell density and culture time. Neuroendocrinology 73, pp. 139 - 148 (2001)

Wigger, A.; Loerscher, P.; Weissenbacher, P.; Holsboer, F.; Landgraf, R.: Cross-fostering and cross-breeding of HAB and LAB rats: A genetic rat model of anxiety. Behavior Genetics 31, pp. 371 - 382 (2001)

Wilke, M.; Eidenschink, A.; Müller-Weihrich, S.; Auer, D. P.: MR diffusion imaging and ¹H spectroscopy in a child with medulloblastoma. A case report. Acta Radiologica 42, pp. 39 - 42 (2001)

Wilke, M.; Kaufmann, C.; Grabner, A.; Pütz, B.; Wetter, T. C.; Auer, D. P.: Gray matter-changes and correlates of disease severity in schizophrenia: A statistical parametric mapping study. NeuroImage 13, pp. 814 - 824 (2001)

Winkelmann, J.; Schadrack, J.; Wetter, T. C.; Zieglgänsberger, W.; Trenkwalder, C.: Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Medicine 2, pp. 57 - 61 (2001)

Winkelmann, J.; Trenkwalder, C.: Pathophysiologie des Restless-legs-Syndroms. Nervenarzt 72, pp. 100 - 107 (2001)

Wittchen, H.: Introduction - Optimizing outcomes of treating depression: Meeting patient expectations. Journal of Clinical Psychiatry 62 (Suppl. 26), pp. 3 - 4 (2001)

Wittchen, H.-U.: Komorbidität: Angst und Depression. Editorial. Schwerpunktbeitrag. Seroxat-News 3, pp. 2 - 7 (2001)

Wittchen, H.-U.: Optimizing outcomes of treating depression: meeting patient expectations. Journal of Clinical Psychiatry 62 (Suppl. 26), pp. 3 - 4 (2001)

Wittchen, H.-U.; Höfler, M.; Meister, W.: Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? International Clinical Psychopharmacology 16, pp. 121 - 135 (2001)

Wittchen, H.; Holsboer, F.; Jacobi, F.: Met and unmet needs in the management of depressive disorder in the community and primary care: The size and breadth of the problem. Journal of Clinical Psychiatry 62 (Suppl. 26), pp. 23 - 28 (2001)

Wittchen, H.-U.; Hoyer, J.: Generalized anxiety disorder: nature and course. Journal of Clinical Psychiatry 62 (Suppl. 11), pp. 15 - 19 (2001)

Wittchen, H.-U.; Hoyer, J.; Beesdo, K.; Krause, P.: Probleme und Defizite in der hausärztlichen Versorgung von generalisierten Angststörungen. Konsequenzen der GAD-P-Studie und Prioritäten für eine verbesserte Versorgung. Fortschritte der Medizin 119 (Orig. Sonderh. I), pp. 42 - 49 (2001)

Wittchen, H.-U.; Hoyer, J.; Friis, R.: Generalized anxiety disorder - a risk factor for depression? International Journal of Methods in Psychiatric Research 10, pp. 52 - 57 (2001)